Hemifacial Spasm
Hemifacial Spasm
Explore linked clinical trials. Standard reference: MESH:M00290592 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effects of DaxibotulinumtoxinA for Blepharospasm and Hemifacial Spasm | Hemifacial Spasm, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Spasm, Stomatognathic Diseases, benign essential blepharospasm, mouth disorder, nervous system disorder | Recruiting | Phase 4 | 2026-04-23 | NCT06195241 | |
| Prospective Register Study to Assess Eligibility for and Efficacy of Surgical Treatment in Patients With nEuRovascular Conflict | Facial Pain, Glossopharyngeal Nerve Diseases, Hemifacial Spasm, Neurologic Manifestations, Neuromuscular Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Spasm, Stomatognathic Diseases, cranial nerve neuropathy, facial nerve disorder, facial neuralgia, glossopharyngeal neuralgia, mouth disorder, nervous system disorder, trigeminal nerve disorder, trigeminal neuralgia | Not yet recruiting | Not stated | 2025-08-21 | NCT07135024 |